China Resources Sanjiu Medical & Pharmaceutical
China Resources Sanjiu Medical & Pharmaceutical Co Ltd is a pharmaceutical manufacturing company headquartered in Shenzhen, China. The firm researches, produces, and markets over-the-counter medicines, prescription drugs, and traditional Chinese medicine formulations. Its core product portfolio includes cold remedies, dermatological treatments, cardiovascular medicines, and consumer health supplements. Principal revenue is derived from wholesale pharmaceutical sales to hospitals, distributors, and retail pharmacy networks across China. The business targets domestic consumer health and clinical treatment markets as part of the China Resources Group. China Resources Sanjiu Medical & Pharmaceutical is listed on the Shenzhen Stock Exchange.
7 of the funds FundTelligence covers report a position in China Resources Sanjiu Medical & Pharmaceutical.
- Sector
- Health Care
- Country
- China
- Funds holding it
- 7
Funds holding China Resources Sanjiu Medical & Pharmaceutical
- Nordea Stable Emerging Markets — Nordea Funds · 0.46 % (full portfolio disclosed, July 2026)
- Nordea Stabil Balanceret — Nordea Funds · 0.04 % (full portfolio disclosed, July 2026)
- Nordea Stable Return Fund — Nordea Funds · 0.04 % (full portfolio disclosed, July 2026)
- Danske Invest Global Emerging Markets Index Restricted — Danske Invest · 0.02 % (full portfolio disclosed, July 2026)
- Handelsbanken Global Index Criteria — Handelsbanken · 0.01 % (full portfolio disclosed, September 2026)
- BlackRock iShares MSCI EM IMI Screened UCITS ETF — BlackRock · 0.0 % (full portfolio disclosed, October 2026)
- Handelsbanken Emerging Markets Index — Handelsbanken · 0.0 % (full portfolio disclosed, September 2026)